Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening

7 Jun 2022

Abstract excerpt

Cell-free DNA is an advancing technology with increasing applications in screening, diagnosis, and treatment for several disease processes. The shared physiologic, genetic, and epigenetic characteristics of placental physiology and tumor development have become apparent to both clinicians and researchers. Maternal malignancy has been reported as a cause of false-positive prenatal cell-free DNA screening results....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Prenatal Screening and Diagnostics
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35849469
DOI: 10.1097/aog.0000000000004833

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA ScreeningPMID 35849469Read ↗

Maternal Malignancy Evaluation After Discordant Cell-Free DNA ResultsSemantic proximity Read ↗

Placental, maternal, fetal, and technical origins of false-positive cell-free DNA screening resultsSemantic proximity Read ↗

Pregnant women with confirmed neoplasms should not have noninvasive prenatal testingSemantic proximity Read ↗

Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal TestingSemantic proximity Read ↗

Implications of fetoplacental mosaicism on cell‐free <scp>DNA</scp> testing: a review of a common biological phenomenonSemantic proximity Read ↗

Maternal Malignancy After Atypical Findings on Single-Nucleotide Polymorphism-Based Prenatal Cell-Free DNA Screening.Semantic proximity Read ↗

Cell-Free DNA ScreeningSemantic proximity Read ↗

Non-invasive prenatal diagnosis (NIPD): current and emerging technologiesSemantic proximity Read ↗

Prenatal cfDNA Sequencing and Incidental Detection of Maternal CancerSemantic proximity Read ↗

Performance of non‐invasive prenatal testing when fetal cell‐free <scp>DNA</scp> is absentSemantic proximity Read ↗

Advances in Prenatal Cell‐Free DNA Screening for Dominant Monogenic Conditions: A Review of Current Progress and Future Directions in Clinical ImplementationSemantic proximity Read ↗

Clinical Perspective of Cell-Free DNA Testing for Fetal AneuploidiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.